Early clinical outcomes of a novel rheolytic directional thrombectomy technique for patients with iliofemoral deep vein thrombosis
Authors:
Open Access
- 1 January 2018
- journal article
- research article
- Published by Hogrefe Publishing Group in Vasa
- Vol. 47 (1) , 56-62
Abstract
Background: Rheolytic thrombectomy (RT) for acute iliofemoral deep vein thrombosis (DVT) with first-generation techniques is often incomplete and adjunctive conventional catheter-directed thrombolysis (CDT) is required in more than half of patients to achieve venous patency. Patients and methods: From the prospective Bern Venous Stent Registry, we investigated rates of primary treatment success, primary patency, and post-thrombotic syndrome (PTS) from 40 consecutive patients (mean age 51 ± 19 years, 45 % women) with acute iliofemoral DVT, treated with a novel directional RT technology and stent placement. Overall, 24 patients were treated for native-vessel iliofemoral DVT (11 with single-session RT, 13 with bail-out RT after failed CDT) and 16 for iliofemoral stent thrombosis. Pulse-spray thrombolysis (r-tPA 10 mg) was performed in 29 (73 %) patients. The mean follow-up duration was 193 ± 132 days (minimum 90 days). Results: Overall, primary treatment success of RT was 95 %; only two patients required adjunctive CDT to restore patency. In 24 patients with native-vessel DVT, six-month primary patency was 92 % (95 %CI 75–99 %), and 23 patients (96 %) were free from the PTS according to the Villalta score. In 16 patients with stent thrombosis, six-month primary patency was 63 % (95 %CI 35–85 %) and 50 % were free from PTS. Except for transient macroscopic haemoglobinuria in all patients, no other side effects were recorded. Conclusions: In patients with iliofemoral DVT of native or stented vessels, RT followed by stent placement appears to be effective and safe. The novel technique enables single-session DVT treatment in the majority of patients without the need for prolonged CDT.Keywords
This publication has 18 references indexed in Scilit:
- Postthrombotic morbidity correlates with residual thrombus following catheter-directed thrombolysis for iliofemoral deep vein thrombosisJournal of Vascular Surgery, 2012
- Economic burden and cost determinants of deep vein thrombosis during 2 years following diagnosis: a prospective evaluationJournal of Thrombosis and Haemostasis, 2011
- Revision of the venous clinical severity score: Venous outcomes consensus statement: Special communication of the American Venous Forum Ad Hoc Outcomes Working GroupJournal of Vascular Surgery, 2010
- Endovenous therapy for deep venous thrombosis: The TORPEDO trialCatheterization and Cardiovascular Interventions, 2010
- Quantity of clot lysed after catheter-directed thrombolysis for iliofemoral deep venous thrombosis correlates with postthrombotic morbidityJournal of Vascular Surgery, 2010
- Determinants and Time Course of the Postthrombotic Syndrome after Acute Deep Venous ThrombosisAnnals of Internal Medicine, 2008
- Determinants of health‐related quality of life during the 2 years following deep vein thrombosisJournal of Thrombosis and Haemostasis, 2008
- Economic burden of deep-vein thrombosis, pulmonary embolism, and post-thrombotic syndromeAmerican Journal of Health-System Pharmacy, 2006
- The post-thrombotic syndrome: risk factors and impact on the course of thrombotic diseaseJournal of Thrombosis and Haemostasis, 2005
- The post-thrombotic syndrome: incidence and prognostic value of non-invasive venous examinations in a six-year follow-up studyThrombosis and Haemostasis, 2005